Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-25-000219
Filing Date
2025-04-09
Accepted
2025-04-09 16:10:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8702
  Complete submission text file 0000904454-25-000219.txt   10537
Mailing Address 11 HUGHES IRVINE CA 92618
Business Address 11 HUGHES IRVINE CA 92618 949-427-7785
Beta Bionics, Inc. (Subject) CIK: 0001674632 (see all company filings)

EIN.: 475386878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94834 | Film No.: 25825314
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O SANDS CAPITAL VENTURES, LLC 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209
Business Address C/O SANDS CAPITAL VENTURES, LLC 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209 703-562-4000
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by) CIK: 0001875620 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: SCHEDULE 13G